Joint Discomfort: Some research has reported findings of joint discomfort or stiffness in subjects getting IGF1 LR3
Research has shown that, on average, people who are overweight or living with obesity can lose anywhere from roughly 10% to 20% of their total body weight on a GLP-1, depending on factors like which drug they use, what dose they take, and how long they continue treatment
For methionine, vitamin D, and GSH, age, sex, publication year, and latitude did not significantly affect the study outcome (eFig
Many encounter hurdles associated with prescription rules, insurance rules, and out-of-pocket costs
Electrolyte supplementation addresses the dehydration component and is one of the most effective tools for managing GLP-1 fatigue
Kidney Protection (SURPASS-4) Heerspink HJL, Sattar N, Pavo I, et al